Denali Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DNLI and other ETFs, options, and stocks.About DNLI
Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Its product pipeline includes LRRK2, RIPK1, TREM2, and Tau.
DNLI Key Statistics
Stock Snapshot
With a market cap of 3.44B, Denali Therapeutics(DNLI) trades at $21.62. The stock has a price-to-earnings ratio of -7.52.
On 2026-06-15, Denali Therapeutics(DNLI) stock moved within a range of $20.92 to $22.15. With shares now at $21.62, the stock is trading +3.3% above its intraday low and -2.4% below the session's peak.
Trading volume for Denali Therapeutics(DNLI) stock has reached 2.19M, versus its average volume of 1.89M.
Over the past 52 weeks, Denali Therapeutics(DNLI) stock has traded between a high of $23.77 and a low of $12.58.
Over the past 52 weeks, Denali Therapeutics(DNLI) stock has traded between a high of $23.77 and a low of $12.58.
DNLI News
Denali Therapeutics and Biogen previously halted joint development of BIIB122 for idiopathic Parkinson’s disease after the Phase 2b LUMA trial did not meet its...
Analyst ratings
94%
of 18 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.